FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. and Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
French: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. et Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Portuguese: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C., Wendel, A. (2008). Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Swedish: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. och Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Finnish: Kreiling, R., Hollnagel, H. M., Hareng, L., Eigler, L., Lee, M. S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. ja Wendel, A. (2008). Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Slovenian: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. and Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Estonian: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. and Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Latvian: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. and Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
Maltese: Kreiling, R., Hollnagel, H.M., Hareng, L., Eigler, L., Lee, M.S., Griem, P., Dreessen, B., Kleber, M., Albrecht, A., Garcia, C. u Wendel, A. (2008), Comparison of the skin sensitising potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
English: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
French: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. et Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Portuguese: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R., Mehling, A. (2009). Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Swedish: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. och Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Finnish: Basketter, D., Ball, N., Cagen, S., Carrillo, J. C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. ja Mehling, A. (2009). Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Slovak: Basketter, D., Ball, N., Cagen, S., Carrillo, J. C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Slovenian: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Estonian: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Latvian: Basketter, D., Ball, N., Cagen, S., Carrillo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
English: Crouch, S.P., Kozlowski, R., Slater, K.J. and Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
French: Crouch, S.P., Kozlowski, R., Slater, K.J. et Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Portuguese: Crouch, S.P., Kozlowski, R., Slater, K.J., Fletcher J. (1993). The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Swedish: Crouch, S.P., Kozlowski, R., Slater, K.J. och Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Finnish: Crouch, S. P., Kozlowski, R., Slater, K. J. ja Fletcher J. (1993). The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Slovak: Crouch, S. P., Kozlowski, R., Slater, K. J. and Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Slovenian: Crouch, S.P., Kozlowski, R., Slater, K.J. and Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Estonian: Crouch, S.P., Kozlowski, R., Slater, K.J. and Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
Latvian: Crouch, S.P., Kozlowski, R., Slater, K.J. and Fletcher J. (1993), The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
English: Ishizaka, A., Tono-oka, T. and Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
French: Ishizaka, A., Tono-oka, T. et Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Portuguese: Ishizaka, A., Tono-oka, T., Matsumoto, S. (1984). Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Swedish: Ishizaka, A., Tono-oka, T. och Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Finnish: Ishizaka, A., Tono-oka, T. ja Matsumoto, S. (1984). Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Slovak: Ishizaka, A., Tono-oka, T. and Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Slovenian: Ishizaka, A., Tono-oka, T. and Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Estonian: Ishizaka, A., Tono-oka, T. and Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
Latvian: Ishizaka, A., Tono-oka, T. and Matsumoto, S. (1984), Evaluation of the proliferative response of lymphocytes by measurement of intracellular ATP.
English: Dexter, S.J., Cámara, M., Davies, M. and Shakesheff, K.M.
French: Dexter, S.J., Cámara, M., Davies, M. et Shakesheff, K.M.
Portuguese: Dexter, S.J., Cámara, M., Davies, M., Shakesheff, K.M.
Swedish: Dexter, S.J., Cámara, M., Davies, M. och Shakesheff, K.M.
Finnish: Dexter, S. J., Cámara, M., Davies, M. ja Shakesheff, K. M. (2003).
Slovenian: Dexter, S.J., Cámara, M., Davies, M. and Shakesheff, K.M.
Estonian: Dexter, S.J., Cámara, M., Davies, M. and Shakesheff, K.M.
Latvian: Dexter, S.J., Cámara, M., Davies, M. and Shakesheff, K.M.
English: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
French: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
Portuguese: Lundin A. (2000). Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
Finnish: Lundin A. (2000). Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Meth.
Slovak: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
Slovenian: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
Estonian: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
Latvian: Lundin A. (2000), Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites.
English: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
French: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay. NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Sciences.
Portuguese: ICCVAM (2009). Recommended Performance Standards: Murine Local Lymph Node Assay. NIH Publication Number 09-7357. Research Triangle Park, NC.
Swedish: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09–7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
Finnish: ICCVAM (2009). Recommended Performance Standards: Murine Local Lymph Node Assay. NIH-julkaisunumero 09-7357.
Slovak: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
Slovenian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
Estonian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
Latvian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
Lithuanian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09–7357, Research Triangle Park, NC: National Institute of Environmental Health Science.
English: Kimber, I., Dearman, R.J., Scholes E.W. and Basketter, D.A.
French: Kimber, I., Dearman, R.J., Scholes E.W. et Basketter, D.A.
Portuguese: Kimber, I., Dearman, R.J., Scholes E.W., Basketter, D.A.
Swedish: Kimber, I., Dearman, R.J., Scholes E.W. och Basketter, D.A.
Finnish: Kimber, I., Dearman, R. J., Scholes E. W. ja Basketter, D. A. (1994).
Slovenian: Kimber, I., Dearman, R.J., Scholes E.W. and Basketter, D.A.
Estonian: Kimber, I., Dearman, R.J., Scholes E.W. and Basketter, D.A.
Latvian: Kimber, I., Dearman, R.J., Scholes E.W. and Basketter, D.A.
English: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
French: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Portuguese: ICCVAM (2009). Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Finnish: ICCVAM (2009). Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Slovak: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Slovenian: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Estonian: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
Latvian: ICCVAM (2009), Nonradioactive Murine Local Lymph Node Assay: Flow Cytometry Test Method Protocol (LLNA: BrdU-FC) Revised Draft Background Review Document.
English: Patterson, R.M., Noga, E. and Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
French: Patterson, R.M., Noga, E. et Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Portuguese: Patterson, R.M., Noga, E., Germolec, D. (2007). Lack of evidence for contact sensitisation by Pfiesteria extract.
Swedish: Patterson, R.M., Noga, E. och Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Finnish: Patterson, R. M., Noga, E. ja Germolec, D. (2007). Lack of evidence for contact sensitisation by Pfiesteria extract. Environ.
Slovak: Patterson, R. M., Noga, E., and Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Slovenian: Patterson, R.M., Noga, E. and Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Estonian: Patterson, R.M., Noga, E. and Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Latvian: Patterson, R.M., Noga, E. and Germolec, D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
English: Also referred to as within-laboratory reproducibility (38). Outlier An outlier is an observation that is markedly different from other values in a random sample from a population.
French: On parle aussi de reproductibilité entre laboratoires (38).
Swedish: Utanförliggande värde Ett utanförliggande värde (’outlier’) är en observation som markant skiljer sig från de övriga värdena i ett slumpmässigt urval från en population.
Finnish: Laboratorionsisäinen uusittavuus Se, missä määrin pätevä laboratoriohenkilöstö voi (kyseisessä laboratoriossa) saada onnistuneesti aikaan samat tulokset käyttämällä tiettyä tutkimussuunnitelmaa eri ajankohtina (38).
Estonian: Laborisisene reprodutseeritavus suurus, mis näitab, millisel määral suudavad sama labori kvalifitseeritud töötajad konkreetset katse-eeskirja kasutades saada kordusuuringutes eri aegadel samasuguseid tulemusi (38).
English: Takeyoshi, M., Iida, K., Shiraishi, K. and Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Portuguese: Takeyoshi, M., Iida, K., Shiraishi, K., Hoshuyama, S. (2005). Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Swedish: Takeyoshi, M., Iida, K., Shiraishi, K. och Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Finnish: Takeyoshi, M., Iida, K., Shiraishi, K. ja Hoshuyama, S. (2005). Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay. J. Appl.
Slovak: Takeyoshi, M., Iida, K., Shiraishi, K. and Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Slovenian: Takeyoshi, M., Iida, K., Shiraishi, K. and Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Estonian: Takeyoshi, M., Iida, K., Shiraishi, K. and Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Latvian: Takeyoshi, M., Iida, K., Shiraishi, K. and Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
Maltese: Takeyoshi, M., Iida, K., Shiraishi, K. u Hoshuyama, S. (2005), Novel approach for classifying chemicals according to skin sensitising potency by non-radioisotopic modification of the local lymph node assay.
English: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Portuguese: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R., Mehling, A. (2009). Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Swedish: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. och Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Finnish: Basketter, D., Ball, N., Cagen, S., Carrilo, J. C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. ja Mehling, A. (2009). Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Slovak: Basketter, D., Ball, N., Cagen, S., Carrilo, J. C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Slovenian: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Estonian: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Latvian: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. and Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
Maltese: Basketter, D., Ball, N., Cagen, S., Carrilo, J.C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R. u Mehling, A. (2009), Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
English: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay.
Portuguese: ICCVAM (2009). Recommended Performance Standards: Murine Local Lymph Node Assay.
Finnish: ICCVAM (2009). Recommended Performance Standards: Murine Local Lymph Node Assay.
Slovak: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay.
Slovenian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay.
Estonian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay.
Latvian: ICCVAM (2009), Recommended Performance Standards: Murine Local Lymph Node Assay.
English: Patterson, R.M., Noga, E. and Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Portuguese: Patterson, R.M., Noga, E., Germolec D. (2007). Lack of evidence for contact sensitisation by Pfiesteria extract.
Swedish: Patterson, R.M., Noga, E. och Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Finnish: Patterson, R. M., Noga, E. ja Germolec D. (2007). Lack of evidence for contact sensitisation by Pfiesteria extract. Environ.
Slovak: Patterson, R. M., Noga, E. and Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Slovenian: Patterson, R.M., Noga, E. and Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Estonian: Patterson, R.M., Noga, E. and Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Latvian: Patterson, R.M., Noga, E. and Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
Maltese: Patterson, R.M., Noga, E. u Germolec D. (2007), Lack of evidence for contact sensitisation by Pfiesteria extract.
English: Also referred to as within-laboratory reproducibility (33). Outlier An outlier is an observation that is markedly different from other values in a random sample from a population.
French: On parle aussi de reproductibilité entre laboratoires (33).
Swedish: Reproducerbarhet inom laboratoriet Ett mått på i vilken utsträckning kvalificerade personer inom samma laboratorium framgångsrikt kan upprepa resultat vid olika tidpunkter när de använder ett visst protokoll (33).
Finnish: Laboratorionsisäinen uusittavuus Se, missä määrin tietyn laboratorion pätevä henkilöstö voi saada onnistuneesti aikaan samat tulokset käyttämällä tiettyä tutkimussuunnitelmaa eri ajankohtina (33).
Estonian: Laborisisene reprodutseeritavus suurus, mis näitab, millisel määral suudavad sama labori kvalifitseeritud töötajad konkreetset katse-eeskirja kasutades saada kordusuuringutes eri aegadel samasuguseid tulemusi (33).
English: In certain situations, when there is a regulatory need to confirm a negative prediction of skin sensitising potential, an optional rLLNA protocol (16) (17) (18) using fewer animals may be used, provided there is adherence to all other LLNA protocol specifications in this TM. Before applying the rLLNA approach, clear justifications and scientific rationale for its use should be provided.
Finnish: Vaihtoehtoista, vähemmän koe-eläimiä käyttävää rLLNA-menetelmää (16) (17) (18) voidaan soveltaa tietyissä tapauksissa, joissa ihoherkistyspotentiaalin negatiivinen oletus on sääntelysyistä vahvistettava, edellyttäen että kaikkia muita tässä testimenetelmässä kuvattuja LLNA-menettelyn vaatimuksia noudatetaan. rLLNA-menettelyn käyttö on perusteltava selvästi ja tieteellisesti ennen menetelmän käyttöä.
English: Conclusions and recommendations of an independent scientific peer review panel, Reg. Toxicol.
Portuguese: Conclusions and recommendations of an independent scientific peer review panel. Reg. Toxicol.
Dutch: Toxicol.
Finnish: Conclusions and recommendations of an independent scientific peer review panel. Reg. Toxicol.
English: Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods, Reg. Toxicol.
Portuguese: Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods. Reg. Toxicol.
Dutch: Toxicol.
Finnish: Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods. Reg. Toxicol.